Rationale: Mucinous liposarcoma myxoid liposarcoma is a malignant mucoid soft tissue tumor derived from undifferentiated stromal cells in perivascular, subbody cavity and intermuscular space, and composed of cells at different stages of differentiation from preadipocytes to mature cells. In rare cases, it may change from lipoma malignancy. The main manifestations is painless mass, relatively slow growth, the course can last decades, the prevalence of liposarcoma in the population is 14% to 18%, mainly in adults, male prevalence is higher than women, but not significant. The main good hair part is the thigh, have mucinous sex, high differentiation type, dedifferentiation type, polymorphic type. Clinical diagnosis is difficult, and there are no obvious symptoms in the early stage, so the diagnosis should be combined with B ultrasound, MRI, CT, and other auxiliary examinations. The gold standard is pathological examination. In December 2023, our department admitted a patient with a mucinous abdominal mass. The report is as follows.

Patient Concerns: Does liposarcoma metastasize? Is any chemotherapy required after surgery? Will it ever relapse in the future? What is the survival period after surgery?

Diagnosis: Mucinous liposarcoma.

Interventions: Surgical resection of the sarcoma.

Results: The nodule sample was 33 * 28 * 13 cm, with complete capsule, gray and yellow sections, fine texture, soft, gray, red, grayish, and yellow mucoid nodules in some areas, and the maximum diameter of the nodules was 21cm. Immunohistochemistry was: CD34 (+), CDK 4 (+), CK (-), Desmin (weak +), Ki67 (index 5%), MDM 2 (-), p16 (weak +), S-100P (+), Vimentin (+), BCL-2 (+). He was also sent to the Department of Pathology of Peking Union Medical College Hospital for consultation with Professor Lu Zhaohui, whose consultation opinion was in line with myxoliposarcoma.

Conclusion: Retroperitoneal liposarcoma is a common retroperitoneal tumor, but it is relatively rare in clinical practice; the overall morbidity is low, mainly manifested as abdominal pain and abdominal distension, abdominal distension, and a long course of disease; it is not sensitive to radiotherapy and chemotherapy, and should be closely follow up by CT examination to understand the recurrence and metastasis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11332703PMC
http://dx.doi.org/10.1097/MD.0000000000039282DOI Listing

Publication Analysis

Top Keywords

mucinous liposarcoma
8
abdominal distension
8
liposarcoma
6
abdominal
5
giant mucinous
4
liposarcoma abdominal
4
abdominal cavity
4
cavity case
4
case report
4
report rationale
4

Similar Publications

Echocardiography-Guided Radiofrequency Ablation for Cardiac Tumors.

JACC CardioOncol

August 2024

Xijing Ultrasound Interventional Treatment Center for Cancer, Department of Ultrasound, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.

Article Synopsis
  • Patients with cardiac tumors often face difficulties with surgery due to their poor health, and a new procedure called TARFACT offers a less invasive way to provide palliative care.
  • The study involved five patients with various types of cardiac tumors who underwent TARFACT, followed by comprehensive assessments through different medical tests.
  • Results showed significant reductions in tumor size, improved heart function, and better overall health in most patients over a follow-up period, indicating TARFACT’s potential as a viable treatment option.
View Article and Find Full Text PDF

Case report: Ovarian mucinous tumor with a mural nodule of liposarcoma: a rare case.

Front Oncol

August 2024

Provincial Clinical Medical College of Fujian Medical University, Department of Pathology, Fujian Provincial Hospital, Fuzhou, China.

Article Synopsis
  • Ovarian mucinous tumors with mural nodules are uncommon and can include different types of nodules, with true sarcomatous nodules being particularly rare, evidenced by only 10 reported cases globally.
  • A 91-year-old woman was diagnosed with an ovarian mucinous cystadenoma containing a well-differentiated liposarcoma mural nodule, which has not been previously documented.
  • Genetic testing revealed distinct mutations for the ovarian mucinous cystadenoma, while the liposarcoma mural nodule showed no mutations but had specific copy number amplifications and a unique mutation, indicating differences in their genetic profiles.
View Article and Find Full Text PDF

Rationale: Mucinous liposarcoma myxoid liposarcoma is a malignant mucoid soft tissue tumor derived from undifferentiated stromal cells in perivascular, subbody cavity and intermuscular space, and composed of cells at different stages of differentiation from preadipocytes to mature cells. In rare cases, it may change from lipoma malignancy. The main manifestations is painless mass, relatively slow growth, the course can last decades, the prevalence of liposarcoma in the population is 14% to 18%, mainly in adults, male prevalence is higher than women, but not significant.

View Article and Find Full Text PDF

Prostatic stromal tumor of uncertain malignant potential: a case report and literature review.

J Int Med Res

May 2024

Department of Urology, Peking University Shenzhen Hospital, Institute of Urology, Shenzhen PKU-HKUST Medical Center, Shenzhen, China.

Article Synopsis
  • * A guy in his early 40s had STUMP but didn't have high PSA levels; he had painful symptoms for over 7 months before doctors figured it out.
  • * After an MRI showed something unusual and a biopsy confirmed he had mucinous liposarcoma, he had surgery and the doctors learned more about diagnosing and treating this rare condition.
View Article and Find Full Text PDF

To investigate the clinicopathological and molecular genetic characteristics of well-differentiated/dedifferentiated liposarcoma (WDLPS/DDLPS) with myxoid-like morphology, and to distinguish them from myxofibrosarcoma (MFS) with similar morphology. Twenty-nine cases of myxoid-like liposarcoma and 5 cases of MFS were collected from Henan Provincial People's Hospital, Zhengzhou, China and the First Medical Center of PLA General Hospital, Beijing, China from January 2015 to March 2023. Relevant markers were detected using immunohistochemistry and fluorescence in situ hybridization (FISH).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!